Friday, March 10, 2017 12:15:28 PM
I noticed before and I'm going to repeat myself because it goes to the point of how the transition was done. As an example, if you look at the studies on the website, they're taken from Injex and the name "Inolife" has merely been inserted in the text. You can make out a slight difference in the font. Also, in one picture which is not text, you'll still see the name "Injex".
The name "Medical Marketing Berlin" is also a dead giveaway that these studies were done for the German manufacturer, not the current owner of this ticker. Here's an old press release that shows this.
http://www.dgap.de/dgap/News/dgap_media/successful-takeover-injex-pharma-gmbh-needle-free-syringe-mmb-medical-marketing-berlin-gmbh-paketeria-ag/?newsID=687602
You can lead a horse to water. But you can't make him get down on one knee and do an Al Jolson impression!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM